These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 7697679

  • 1. Membranous glomerulonephritis in patients with rheumatoid arthritis.
    Yoshida A, Morozumi K, Takeda A, Koyama K, Oikawa T.
    Clin Ther; 1994; 16(6):1000-6. PubMed ID: 7697679
    [Abstract] [Full Text] [Related]

  • 2. Bucillamine induces membranous glomerulonephritis.
    Nagahama K, Matsushita H, Hara M, Ubara Y, Hara S, Yamada A.
    Am J Kidney Dis; 2002 Apr; 39(4):706-12. PubMed ID: 11920335
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinicopathological study of nephropathy in patients with rheumatoid arthritis].
    Yoshida A, Morozumi K, Suganuma T, Aoki J, Sugito K, Koyama K, Oikawa T, Fujinimi T, Matsumoto Y.
    Ryumachi; 1991 Feb; 31(1):14-21. PubMed ID: 1677490
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis.
    Obayashi M, Uzu T, Harada T, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Dec; 7(4):275-8. PubMed ID: 14712356
    [Abstract] [Full Text] [Related]

  • 8. Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature.
    Honkanen E, Törnroth T, Pettersson E, Skrifvars B.
    Clin Nephrol; 1987 Feb; 27(2):87-93. PubMed ID: 3829481
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A case of malignant rheumatoid arthritis complicated by secondary amyloidosis and membranous nephropathy].
    Nakanishi K, Iwahashi C, Handa Y, Hara N, Hamada K, Nagai Y, Kawamura S, Nakamura K.
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):607-11. PubMed ID: 9893461
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. "Yellow nail syndrome" and rheumatoid arthritis.
    Ichikawa Y, Shimizu H, Arimori S.
    Tokai J Exp Clin Med; 1991 Dec; 16(5-6):203-9. PubMed ID: 1820660
    [Abstract] [Full Text] [Related]

  • 16. Membranous nephropathy with crescents in rheumatoid arthritis: a case report.
    Dohi K, Shiiki H, Kawano T, Kanauchi M, Ishikawa H, Watanabe T.
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):523-7. PubMed ID: 1895551
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Outcome and treatment of bucillamine-induced nephropathy.
    Hoshino J, Ubara Y, Hara S, Suwabe T, Sawa N, Tagami T, Katori H, Takemoto F, Hara S, Takaichi K.
    Nephron Clin Pract; 2006 May; 104(1):c15-9. PubMed ID: 16685139
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.